QuickView for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=8CAE4D2F6D2ADAA7000690C3A4BABDF2;jsessionid=59527D2BB9ADB40D0FF86D690D2CAA77;jsessionid=4611458D3173AC9A7FB1296B151D0C12;jsessionid=636E97E918E33141C83BCCD0DC6CB41A;jsessionid=816C1DB4C8394B8E19A693B66C06C1A1;jsessionid=192BA595AF6DAD169ACDFE5357F38A2D;jsessionid=43358BA8266BC38E44AA61C4334B2858;jsessionid=6C789441DEDBAB08E7140BB3E6A513DF;jsessionid=3C85B3278CAFA2241BEF4F1559DE4723;jsessionid=9375463DCD0030E6B13DF418A99A9B86;jsessionid=8B0EDFFDA6B1B85F307E22C1FFA4F865;jsessionid=D1ABFE53FB9A38B81FA39D5A18618532 (gene)

1. AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistan…
2. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Mat…
3. A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
4. Cooperative Nucleotide Binding in Hsp90 and Its Regulation by Aha1.
5. A Split Renilla Luciferase Complementation Assay for the Evaluation of Hsp90/Aha1 Complex Disruptors…

There were no clinical trials for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=8CAE4D2F6D2ADAA7000690C3A4BABDF2;jsessionid=59527D2BB9ADB40D0FF86D690D2CAA77;jsessionid=4611458D3173AC9A7FB1296B151D0C12;jsessionid=636E97E918E33141C83BCCD0DC6CB41A;jsessionid=816C1DB4C8394B8E19A693B66C06C1A1;jsessionid=192BA595AF6DAD169ACDFE5357F38A2D;jsessionid=43358BA8266BC38E44AA61C4334B2858;jsessionid=6C789441DEDBAB08E7140BB3E6A513DF;jsessionid=3C85B3278CAFA2241BEF4F1559DE4723;jsessionid=9375463DCD0030E6B13DF418A99A9B86;jsessionid=8B0EDFFDA6B1B85F307E22C1FFA4F865;jsessionid=D1ABFE53FB9A38B81FA39D5A18618532